Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients
Clinical trial NCT04867720 · UNKNOWN
Trial details
- NCT number
- NCT04867720
- Sponsor
- Chong Kun Dang Pharmaceutical
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-16
- Primary completion
- 2022-10-10
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.